April 16, 2009

Stirling Products announced that its North American subsidiary, Stirling Products North America Inc (STI-NA) has signed an agreement with Canada's national research council for a trial of its lead candidate R-salbutamol in pigs.

The trial will begin next month in 40 pigs at a commercial production facility in Canada.

R-salbutamol is a beta agonist derived from the R isomer of salbutamol, a known metabolic modifier which diverts energy from fat production into increased muscle mass. It will be compared with ractopamine, another beta agonist used to promote lean meat production in pigs.